Are there interactions between bupropion (Wellbutrin) and MDMA (Molly)?

Significant Drug Interaction Between Bupropion (Wellbutrin) and MDMA (Molly)

Yes, there is a clinically significant interaction between bupropion and MDMA that results in increased plasma concentrations of both drugs and prolonged subjective effects of MDMA, though paradoxically with reduced cardiac stimulation. 1

Mechanism of Interaction

Bupropion inhibits both the dopamine and norepinephrine transporters (DAT and NET), which are the same transporters through which MDMA exerts its effects by releasing dopamine and norepinephrine. 1 This creates a bidirectional pharmacokinetic interaction:

• MDMA increases plasma bupropion concentrations 1
• Bupropion increases plasma MDMA concentrations and prolongs MDMA's subjective mood effects 1
• Bupropion is metabolized primarily by CYP2B6, and MDMA inhibits this enzyme, leading to reduced bupropion clearance 2

Clinical Effects of the Interaction

Cardiovascular Effects

• Bupropion reduces MDMA-induced elevations in plasma norepinephrine concentrations 1
• Bupropion reduces the heart rate response to MDMA 1
• This indicates that transporter-mediated norepinephrine release contributes to MDMA's cardiostimulant effects 1

Mood and Subjective Effects

• The combination results in enhanced and prolonged mood effects from MDMA 1
• Bupropion does not appear to modulate the dopamine-mediated mood effects of MDMA 1
• The prolonged subjective effects occur despite reduced cardiac stimulation 1

Safety Concerns and Contraindications

Seizure Risk

Bupropion is contraindicated in patients with seizure disorders, and combining it with other drugs that lower seizure threshold requires extreme caution. 3 MDMA itself can lower seizure threshold, making this combination particularly concerning 2.

Drug Accumulation

The bidirectional increase in plasma concentrations means both drugs accumulate to higher levels than expected, increasing the risk of adverse effects from both substances. 1 This is especially problematic because:

• Bupropion has a maximum recommended dose of 450 mg/day due to dose-dependent seizure risk 2
• Higher MDMA concentrations increase risks of hyperthermia, serotonin syndrome, and other acute toxicities 4, 5

CYP2D6 Inhibition

Bupropion and its metabolites are CYP2D6 inhibitors, which can affect MDMA metabolism and increase exposure to MDMA. 2 The FDA label specifically notes that bupropion can increase exposures of CYP2D6 substrates by 2- to 5-fold 2.

Clinical Recommendations

Patients taking bupropion should be strongly advised to avoid MDMA use entirely due to:

1. Unpredictable drug accumulation of both substances 1
2. Increased seizure risk from the combination 3, 2
3. Prolonged psychoactive effects that may impair judgment and increase risk-taking behavior 1
4. Potential for acute toxicity from elevated MDMA concentrations 4, 5

If Concurrent Use Occurs

If a patient on bupropion has used MDMA, monitor for:

• Signs of serotonin syndrome or MDMA toxicity (hyperthermia, agitation, confusion, tachycardia) 4
• Prolonged psychoactive effects lasting beyond typical MDMA duration 1
• Seizure activity, particularly if bupropion doses are at or near maximum 2
• Neuropsychiatric symptoms including agitation, restlessness, and mood changes 3

The interaction is bidirectional and pharmacologically significant, making this a high-risk combination that should be avoided. 1